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Human B cells produce antibodies, which bind to their cognate antigen based on distinct molecular
properties of the antibody CDR loop. We have analysed a set of 10 antibodies showing a clear difference
in their binding properties to a panel of antigens, resulting in two subsets of antibodies with a distinct
binding phenotype. We call the observed binding multiplicity ‘promiscuous’ and selected physico-
chemical CDRH3 characteristics and conformational preferences may characterise these promiscuous
antibodies. To classify CDRH3 physico-chemical properties playing a role in their binding properties, we
used statistical analyses of the sequences annotated by Kidera factors. To characterise structure-function
requirements for antigen binding multiplicity we employed Molecular Modelling and Monte Carlo based
coarse-grained simulations. The ability to predict the molecular causes of promiscuous, multi-binding
behaviour would greatly improve the efﬁciency of the therapeutic antibody discovery process.
© 2017 Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).Contents
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Immunoglobulins (Ig) are a crucial component of the adaptive
immune response. Adaptive immunity is distinct from innate im-
munity in that it confers a highly speciﬁc defense against invading
pathogens and is capable of creating memory against foreign
molecules (antigens), enabling a rapid response upon repeated
exposure to the same antigen. Immunoglobulins are produced by B
cells and are either displayed on the cell surface, as B cell receptors,
or are secreted into the extracellular environment and circulate as
antibodies in the blood.
Antigen recognition is mediated by the antibody variable re-
gions, which are located at each of the two apical sites on the ‘Y’
arms of the antibody. A huge diversity of speciﬁcities in the anti-
body repertoire is achieved by gene rearrangement processes,
whereby variable (V), diversity (D) and Joining (J) genes recombine
to produce a complete heavy chain (VDJ) or light chain (VJ) variable
gene. The rearranged gene is expressed in conjunction with a
constant region that confers the functional attributes of the anti-
body. The heavy chain and the light chain variable regions of the
immunoglobulin protein fold to form a conserved b-sheet frame-
work interspersed by six hypervariable loops or “complementarity
determining regions” (CDRs), so-called because they come together
to form the antigen-binding site. Amongst the CDRs (there are three
from each chain), the third loop on the heavy chain (CDR-H3) is the
most diverse because it is encoded by a stretch of nucleotides
spanning all three IGHV-D-J gene segments. Similarly, the equiva-
lent light chain region (CDR-L3) is also diverse although not to the
same extent. Site-directed mutagenesis and loop grafting studies
have shown that the H3 loop can be sufﬁcient to deﬁne antibody
speciﬁcity (Xu and Davis, 2000). Crystal structure analyses have
also identiﬁed the CDR-H3 region as being centrally positioned in
the antigen-binding site, always in contact with antigen and, in
some cases, able to change conformation upon binding (Stanﬁeld
and Wilson, 1994). In fact, CDR-H3 is the only exception to the ca-
nonical structuremodel, which has identiﬁed all remaining CDRs as
belonging to one of a few discrete conformations on the basis of
sequence length and composition (Shirai et al., 1996; Chothia and
Lesk, 1987; Chothia et al., 1989; Shirai et al., 1999).
A consequence of the random nature of the Ig gene rearrange-
ment process is that a signiﬁcant proportion of antibodies pro-
duced in the bone marrowmay be autoreactive (Wardemann et al.,
2003). Potentially dangerous autoreactive antibodies must be
removed from the repertoire at tolerance checkpoints in the
development process in order to avoid autoimmune diseases such
as systemic lupus erythematosus (Yurasov et al., 2005) and rheu-
matoid arthritis (Samuels et al., 2005). Some antibodies are capable
of binding multiple chemically and structurally diverse antigens,
which means that although an antibody may be produced with the
potential to usefully bind to exogenous antigens, it may result in
binding to self-antigens. Thus previous literature on tolerance and
autoimmunity will quite often refer to “polyreactivity” of an anti-
body. Polyreactive antibodies occur in normal human sera and arePlease cite this article in press as: Laffy, J.M.J., et al., Promiscuous antibodie
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(Guilbert et al., 1982). They have been shown to cause bacterial lysis
(Zhou et al., 2007a, 2007b), induce complement and clear apoptotic
cells (Zhou et al., 2013). So in the case of polyreactive antibodies a
trade-off balance between potentially useful initial activity and
potentially harmful anti-self effects has to be maintained.
In the literature people refer indiscriminately to polyreactive
and/or polyspeciﬁc antibodies and the deﬁnition intrinsic in the
preﬁx ‘poly’ is matter of debate (Dimitrov et al., 2013). It has been
recently clariﬁed that this term does not refer to the case of mul-
tiple binding due to some stickiness of the antibody chemico-
physical properties and that a large screen over a panel of puta-
tive antigens is needed before extracting antibodies that clearly
react speciﬁcally to a subset of these target antigens. Another term
that is frequently used when referring to antibodies multi-binding
behaviour is promiscuity (James and Tawﬁk, 2003a, 2003b). This
term has long been investigated in the ﬁeld of enzyme binding
(Nobeli et al., 2009), and has been referred to as functional pro-
miscuity, again implying some speciﬁc functional behaviour
resulting from the particular type of binding mode. It is claimed by
Favia at al. (Nobeli et al. 2009) that the term promiscuous may
imply at times what they refer to as ‘invisible’ phenotypes,
observable only under certain conditions. In the past our laboratory
has adopted the term promiscuity as generally applicable to pro-
teins that show multiple partners but may use different strategies
to bind in such a polyvalent way (Fornili et al., 2013). We use
herewith the term promiscuous in referring to a subset of anti-
bodies where binding to a number of tested antigens in the same
experimental conditions were detected, as compared to others that
do not show binding.
Despite its importance in human health and disease, the mo-
lecular basis of antibody multi-binding behaviour remains largely
obscure. Towards this goal, it has been noted that some poly-
reactive antibodies have particularly high frequencies of aromatic
amino acids in the CDR-H3 region (Droupadi et al., 1994) and high
isoelectric points in heavy chain Fv regions. It has also been
hypothesised that exposed hydrophobic patches are associated
with so-called antibody promiscuity (Barbas et al., 1997). Some-
what paradoxically however, a role for speciﬁc hydrogen bonding
has also been proposed (James and Tawﬁk, 2003a). Comparisons of
germline versus antigen-induced antibodies have shown that the
former are more likely to be polyreactive (Chen et al., 1991) and
more ﬂexible (Manivel et al., 2000), which may suggest that one of
the features of polyreactive antibodies is enhanced ﬂexibility. In
support of this, a structural analysis of a promiscuous antibody in
the free and bound states has demonstrated that it adopts a
different conformationwhen bound (James et al., 2003). In contrast
however, Sethi et al. (2006) have more recently shown that struc-
turally diverse epitopes (the precise binding site on the antigen)
bind differentially to a structurally common paratope (the precise
binding site on the antibody), implying that paratope ﬂexibility can
be limited.
Here, we compare the structural properties of ten antibodies,s characterised by their physico-chemical properties: From sequence
6), http://dx.doi.org/10.1016/j.pbiomolbio.2016.09.002
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immunosorbent assay (ELISA) and six that did not show any
binding to the antigens tested. Since the encoding sequences had
quite similar characteristics, we wanted to investigate the nature of
the promiscuous phenotype and whether the structural properties
of the antibody recognition regionswere very different in these two
datasets.
Using computational methods of Molecular Modelling, Kidera
factor clustering and Monte Carlo conformational sampling, we
identiﬁed physico-chemical properties of the CDR-H3 that are
capable of distinguishing between the two phenotypes of antibody
presented in this study.
2. Materials and methods
2.1. Identiﬁcation of antibody heavy and light chain variable region
sequences for cloning
The heavy and light chain variable region sequences for the ten
antibodies used in this study are shown in Supplementary Mate-
rials Table S1. The heavy and light chain sequences had been
selected, as part of another study on ageing, from datasets con-
taining unpaired heavy and light chain variable region sequences.
The datasets fromwhich the sequences were selected are available
at http://www.bcell.org.uk. As there was no information on the
natural heavy-light chain pairings, the selected pairing was guided
by known paired sequences in the literature (DeKosky et al., 2015).
2.2. Synthesis of antibodies
The chosen antibody heavy and light chain variable region
nucleotide sequences were synthesised by Integrated DNA Tech-
nologies (Iowa, USA). The variable region sequences were cloned
into heavy (encoding human IgG1 constant region) or light
(encoding human kappa or lambda constant region) chain
expression vectors using Polymerase Incomplete Primer Extension
(PIPE) cloning as described previously (Dodev et al., 2014). Plasmids
were then transfected into Adherent FreeStyleTM 293-F cells (Life
Technologies) using FuGENE HD (Promega) according to the man-
ufacturer's instructions. The transfected cells were maintained at
70e80% conﬂuence at 37 C, 5% CO2 in DMEM GlutaMax (31966;
Gibco) supplemented with 10% (v/v) fetal calf serum (FCS) (Gibco),
penicillin (5000 U/mL, Life Technologies), streptomycin (100 mg/mL,
Life Technologies) and hygromycin-B (50 mg/ml, Life Technologies).
Antibody-containing tissue culture supernatants were collected
seven days post-transfection. The supernatants were centrifuged at
1000 g for 15 min, ﬁltered (0.22 mm ﬁlters, Sartorius) and stored at
4 C until use. Antibody concentration was determined by ELISA
using a standard curve generated from an antibody of known
concentration, as set out in Tiller et al. (2008).
2.3. ELISA
Antibodies in tissue culture supernatant were diluted to 1 mg/ml
in PBS and were tested in triplicate against the following antigens:
dsDNA (D1501, Sigma), lipopolysaccharide (LPS) (L7770, Sigma),
insulin (91077C, SAFC Biosciences) and HEp-2 cell lysate
(ABIN964023, Antibodies-online). Antibodies were also tested in
wells that had been coated with PBS only. The choice of antigens
was based on those commonly used in the literature (Wardemann
et al., 2003; Tiller et al., 2008).
The ELISA protocol was as set out in Tiller et al. (2008) except for
the assay development. Assays were developed by adding 50 ml
OPD substrate (5 mg OPD tablet (P6912-50 TAB, Sigma) dissolved in
10 ml 1 peroxide substrate buffer (34062, Thermo Scientiﬁc) andPlease cite this article in press as: Laffy, J.M.J., et al., Promiscuous antibodie
to structure and back, Progress in Biophysics and Molecular Biology (201incubating in the dark for 30 min. The reaction was stopped using
50 ml 3 M HCl. The optical density was read at 492 nm (OD492). A
result was deemed positive if the mean OD492 was signiﬁcantly
higher than the background (i.e. secondary antibody only).
2.4. Antibody structures
Two structural datasets were built to analyse the distribution of
CDR-H3 lengths in antibodies from all species and from humans,
respectively. The “Non-redundant CDR search” option in SAbDab
(Structural Antibody Database; accessible at <http://opig.stats.ox.
ac.uk/webapps/sabdab>) (Dunbar et al., 2014) was used to
include only complete CDR-H3 regions from crystal structures
solved at a resolution of  3 Å. CDR-H3 lengths were determined
according to the Chothia deﬁnition. The PDB codes for both datasets
are available in the supplementary material (Supplementary Ma-
terials Table S2).
2.5. Antibody modelling
The modelling workﬂow is described in Fig. 1 and the steps are
outlined below.
2.5.1. Step 1: template search
The search for templates was carried out using the PIGS web
server (Prediction of ImmunoGlobulin Structure; available at
<http://www.biocomputing.it/pigs>) (Marcatili et al., 2008, 2014)
and MOE (Molecular Operating Environment; Version 2013.08;
Chemical Computing Group, Montreal, Quebec, Canada). Both
programs are considered to be state of the art in antibody model-
ling but differ in their methodologies (Almagro et al., 2011, 2014)
PIGS employs the “canonical structure” (CS) approach, which rests
on knowledge that ﬁve out of the six CDRs adopt a limited number
of conformations (so-called canonical structures) whose sequence
determinants have been identiﬁed (Chothia and Lesk, 1987;
Chothia et al., 1989). The exception to this, however, is the CDR-
H3, whose sequence length and composition have so far proven
too variable for complete CS rules to be identiﬁed (Shirai et al., 1996,
1999; Kim et al., 1999; Morea et al., 1998; Shirai et al., 1998). Indeed,
matching CDR-H3 conformations becomes increasingly difﬁcult for
cases inwhich the loop is particularly long. In some cases, PIGS was
found to perform less when CDR-H3 sequences were queried, as
previously pointed out (Marcatili et al., 2008, 2014, 2013).
Furthermore, and most important in our case, PIGS does not allow
the user to search for templates speciﬁc to one CDR region. For
these reasons, we used instead the Antibody Homology Modelling
application suite in MOE to search for a CDR-H3 speciﬁc template.
2.5.2. Step 2: HMM multiple sequence alignment
The template and query sequences provide the input for Step 2:
HMM Multiple Sequence Alignment. Heavy chain (IgH) and light
chain (Igk/Igl) alignments are generated independently using
isotype-speciﬁc HMM proﬁles developed by Tramontano and co-
workers, as described inMarcatili et al. (2014). Using this alignment
method, gaps in the sequence are added outwards from the centre
of the CDRs and conserved residues are always aligned.
2.5.3. Step 3: model building and selection
Step 3 requires the combined H-L alignment from Step 2 and the
template structures retrieved in Step 1. 200 structural models are
built using the comparative modelling procedure in MODELLER
(Sali and Blundell, 1993) and the best model is selected using
normalised DOPE scoring as the quality measure. Models with
scores above 1 indicate the presence of nonnative interactions
and were not considered. Models were visualised with Visuals characterised by their physico-chemical properties: From sequence
6), http://dx.doi.org/10.1016/j.pbiomolbio.2016.09.002
Fig. 1. Modelling workﬂow. The pipeline takes the Fv regions of partner heavy and light chain sequences as input in Step 1 (cyan). The search for templates is conducted using the
PIGS web server and the Antibody Homology suite in MOE. A CDR-H3-speciﬁc template is extracted from the MOE search. The PIGS “Same antibody” method is used to search for a
template whose heavy (H) and light (L) chains are the best combined match for the query H and L sequences. If the sequence identity match of either chain in the PIGS template is
below 70%, an additional chain-speciﬁc template is selected using the alternative “Best H and L chain” PIGS strategy. Together with the query H and L sequences, the selected
template sequences are used as input in Step 2 (green). Heavy chain (IgH) and light chain (Igk/Igl) alignments are generated independently using isotype-speciﬁc HMM proﬁles
developed by Tramontano and coworkers, as ﬁrst described in Chailyan et al. (2011). The combined alignment and the template structures identiﬁed in Step 1 are used in Step 3
(orange). 200 models are built using the comparative modelling procedure in MODELLER and the best model is selected using normalised DOPE scoring as the quality measure. In
the last step (blue), the model is used as the starting structure for tCONCOORD simulations. An ensemble of 500 tCONCOORD structures is generated using default parameters. Pink,
input/output; solid red arrow, proceed to the next step in the scheme; dashed red arrow, proceed to a non-immediate step in the scheme.
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(Humphrey et al., 1996).2.5.4. Step 4: conformational sampling
In the last step, the previously selected best model is energy-
minimised using the OPLS-AA force ﬁeld (Robertson et al., 2015)
and then used as the starting structure for tCONCOORD simulations
(Seeliger et al., 2007; Seeliger and De Groot, 2009). From this, anPlease cite this article in press as: Laffy, J.M.J., et al., Promiscuous antibodie
to structure and back, Progress in Biophysics and Molecular Biology (201ensemble of 500 tCONCOORD structures is generated using default
parameters. We used this procedure, analogously to our previous
work (Fornili et al., 2013) because this method efﬁciently samples
the conformational space (see Fig. S6 for root-mean square distri-
bution) and is therefore suited to antibody loop sampling, other-
wise very difﬁcult to tackle with molecular dynamics or any other
atomistic-based sampling. This method is not affected by conver-
gence issues, and has been demonstrated to extract representativess characterised by their physico-chemical properties: From sequence
6), http://dx.doi.org/10.1016/j.pbiomolbio.2016.09.002
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Fig. 2. Promiscuous antibodies identiﬁed by ELISA. Ten candidate promiscuous anti-
bodies were screened for binding against DNA, LPS, insulin and HEp2. Four of these
antibodies (GF1, GF5, GF7 and GF9) gave positive results in all wells. The remaining six
antibodies (GF2, GF3, GF4, GF6, GF8, GF10) produced only negative results. All wells
contained phosphate-buffered saline (PBS) solution with Tween (a non-ionic deter-
gent) acting as a blocking agent. The colour key represents the well coating used. No
Ab, no antibody; No Ag, no antigen.
Fig. 3. CDR-H3 length distributions. Green, antibody PDB structures from all species;
Orange, Human antibody PDB structures. Blue, Human sequences from the peripheral
blood (data from Wu et al. (Wu et al., 2012)); Pink, selected GF sequences. The shaded
green area represents the range of templates' CDR-H3 lengths used in the structural
modelling of GF antibodies. A CDR-H3 length cutoff threshold of more than 40 amino
acids was applied to the PDB set containing all species.
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simulations and experimental data (Fornili et al., 2013).
In essence, tCONCOORD samples alternative conformational
states in-vacuo by fulﬁlling a set of geometrical constraints
extracted from the initial coordinates and interaction types (e.g.,
covalent bonds, hydrogen bonds, salt bridges, or hydrophobic
interactions).
The tCONCOORD constraint deﬁnition is based on a statistical
analysis of high-resolution X-ray structures and includes a ‘solva-
tion score’ measure of hydrogen bond stability (Seeliger et al.,
2007). Based on this description the structure of the protein is
rebuilt many hundreds of times, leading to an ensemble that can be
analysed.
2.6. Clustering analysis
A hierarchical clustering method was employed using the hclust
function in R (v3.2.3) and a Minkowski distance, p, of 4. Antibodies
were clustered according to the Kidera factors of their CDR-3 region
amino acids (Chothia deﬁnition). The Kidera factors have been
derived to encode 188 physical properties of the 20 amino acids
using dimension reduction techniques. They consist of a 10-
dimensional vector of orthogonal factors for each amino acid
(Nakai et al., 1988).
2.7. Secondary structure analysis
Models were ﬁrst protonated using MOE. Secondary structure
predictions were performed with DSSP (Kabsch and Sander, 1983)
and the output was recorded as follows: extended b-strands and b-
bridges as “Beta”; a-helices, 310-helices and p-helices as “Helix”; 3,
4, and 5 turns and non-hydrogen bonded bends as “Turn”; random
coil as “Coil”. Normalised secondary structure probabilities were
calculated for the CDR-H3 and CDR-L3 (Chothia deﬁnition).
The 95% conﬁdence intervals were calculated using a boot-
strapping method (boot() function in R) to generate 100 randomly
resampled subsets for each of the reference datasets. This allowed
any biases resulting from dataset selection to be avoided.
2.8. Conformational analysis
The maximally correlated motion or MCM has been calculated
for the tCONCOORD trajectories. This is usually expressed as a linear
combination of principal components (PCs) derived from a prin-
cipal component analysis (PCA) of the system trajectory. We
considered here only the ﬁrst 2 PCA eigenvector components of the
trajectory as these are contributing mostly to the total Eigenvalue
displacement (in nm2) (Supplementary Materials Fig. S3). To
identify the CDR-3 atoms collective motion, which maximally
correlate with these two PCA components we extracted the pro-
jection of the CDR-3 atoms trajectory onto the 1st and the 2 nd PCs.
Models are available upon request to the authors' e-mails:
Julie MJ Laffy: julie.laffy@kcl.ac.uk;
Franca Fraternali: franca.fraternali@kcl.ac.uk.
3. Results and discussion
3.1. Identiﬁcation of promiscuous antibodies
Ten antibodies were tested in an ELISA against a panel of four
different antigens and blank, uncoated wells. It was found that the
ten antibodies could be classed as showing one of the two following
phenotypes: (i) a negative signal in all the ELISA wells (GF2, GF3,
GF4, GF6, GF8, GF10 in Fig. 2) and (ii) a positive signal in all the
ELISA wells (GF1, GF5, GF7, GF9 in Fig. 2). We named the antibodiesPlease cite this article in press as: Laffy, J.M.J., et al., Promiscuous antibodie
to structure and back, Progress in Biophysics and Molecular Biology (201which showed a positive signal under every ELISA condition in
which they were tested “promiscuous”. Multiple sequence align-
ments of the promiscuous and non-promiscuous antibodies are
shown in Fig. S1.
We note that the promiscuous antibodies showed a positive
signal even in the absence of antigen on the ELISA plate. The
reactive nature of a promiscuous class of antibodies could be such
that one might expect their binding to empty wells in addition to
other antigens. Nevertheless, the promiscuous antibodies clearly
possess a different phenotype to the non-promiscuous antibodies,
which can be detected in this ELISA format, and are relevant to
previous literature where these methods have been extensively
used to assess polyreactivity/autoreactivity (Wardemann et al.,
2003; Tiller et al., 2008; Meffre et al., 2004). We therefore inves-
tigated this phenotype further using computational methods.s characterised by their physico-chemical properties: From sequence
6), http://dx.doi.org/10.1016/j.pbiomolbio.2016.09.002
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Numerous previous studies have shown that the CDR-H3 loop is
much more variable in its sequence length compared to that of the
remaining CDRs, and that this is a critical determinant of its
conformation. Fig. 3 shows the distribution of CDR-H3 lengths of
the ten antibodies investigated in this paper (pink), a human
antibody repertoire (blue) (data from Wu et al. (2012)) and anti-
body structures deposited in the PDB (orange, human; green, all
species).Fig. 4. Promiscuous (red) and non-promiscuous (blue) GF antibodies can be distinguished o
node on the tree is a GF antibody represented by the Kidera factors of its CDR-3 regions. Da
models of the GF antibodies. The CDR-3 regions on the heavy and light chains are highligh
Fig. 5. b-sheet propensities and structure of CDR-H3 residues. Backbone representation of
(Prevelige, 1989): green, strong formers (V,I,M); blue, formers (F,Y,C,T,W,L,Q); yellow, indiffer
according to the result in Fig. 4. GF labels in red denote promiscuous CDR-H3s; blue labels
Please cite this article in press as: Laffy, J.M.J., et al., Promiscuous antibodie
to structure and back, Progress in Biophysics and Molecular Biology (201The CDR-H3 sequence length distribution of the GF antibodies
analysed in this study were found to be longer, on average, when
compared to both the human sequence repertoire and the PDB.
Previous work has associated longer CDR-H3 regions with antibody
binding multiplicity, which may render this observation signiﬁcant
[ref]. It should be noted however that there is no signiﬁcant dif-
ference in length between the promiscuous and non-promiscuous
GF subsets analysed here.
The PDB length distributions displayed a strong preference for
shorter CDR-H3 loops. This may be due to the complicationsn the basis of (A) CDR-3 Kidera properties and (B) CDR-H3 b-sheet occupancy. (A) Each
ta were clustered using the Minkowski metric with a distance p of 4. (B) Structural Fv
ted in red and blue for promiscuous and non-promiscuous cases, respectively.
the CDR-H3 with amino acids coloured according to their propensity to form b-sheet
ent (R,G,A,D); pink, breakers (H,S,K,N,P); red, strong breakers (E). Clusters were deﬁned
denote non-promiscuous CDR-H3s.
s characterised by their physico-chemical properties: From sequence
6), http://dx.doi.org/10.1016/j.pbiomolbio.2016.09.002
Fig. 6. Average secondary structure probabilities in simulation ensembles for i) pro-
miscuous and ii) non-promiscuous CDR-H3 regions. Predictions were calculated using
DSSP. Each antibody is represented by a conformational ensemble of 500 tCONCOORD
structures, such that the total number of structures in i) is 2000 (4 antibodies) and in
ii) is 3000 (6 antibodies). The error bars represent the conﬁdence intervals at the 95%
level, estimated using 100 runs of bootstrap resampling.
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polypeptide. In any case, the discrepancy in CDR-H3 length be-
tween the GF antibodies and the PDB structures meant that our
template search space was conﬁned to the subset of adequate CDR-
H3 lengths illustrated by the shaded green region in Fig. 3.
3.3. Kidera factors and b-sheet propensities are good indicators of
GF promiscuity
Attempts to classify promiscuous antibodies from sequence in-
formation alone have generally been unsuccessful (see review by
Dimitrov et al. (2013)). Although some studies have identiﬁed the
CDR-H3 region as being accountable for the promiscuous nature of
antibodies (Ditzel et al., 1996; Martin et al., 1994; Ichiyoshi and
Casali, 1994), this region is always critical in antigen recognition,
regardless of promiscuous behaviour.
With this in mind, we ﬁrst sought to quantify the sequence-
based similarities amongst the GF antibodies using a hierarchical
clustering method (seeMaterials andMethods) and postulated that
the inclusion of implicit structural information might improve the
quality of our clustering analysis. As such, for each of the ten GF
antibodies, protein sequences within the CDR-H3 and -L3 loops
were assigned Kidera factors (a set of scores, which quantify
physicochemical properties of protein sequences (seeMaterials and
Methods) (Nakai et al., 1988).
The CDR-L3 loop was considered in this analysis, in addition to
the eH3 loop, because of its demonstrable function in conferring
antibody-antigen speciﬁcity. The assignment of Kidera factors to
the two sequence regions were combined to give a score for each of
the ten antibodies, providing a set of scores by which to cluster.
Three principal clusters were deﬁned (Fig. 4A) from this clus-
tering procedure using Minkowski distance as the metric (see
Materials and Methods). Of these clusters, two were comprised
exclusively of either promiscuous or non-promiscuous antibodies.
More speciﬁcally, the largest cluster (Cluster 1) contained 66.7% of
the total number of non-promiscuous antibodies and 0% of the
promiscuous antibodies while Cluster 3 contained 75% of the pro-
miscuous antibodies and 0% of the non-promiscuous antibodies.
Cluster 2, on the other hand, contained a mixture of both classes
(25% of promiscuous cases and 33.3% of non-promiscuous cases).
Promiscuous GF1 and GF7 and non-promiscuous GF2 and GF4 were
the most rooted in their respective clusters, which suggested that
the traits associated with either binding phenotype should be best
represented by these antibodies.
It is worth noting that similar clustering analyses were per-
formed using simpler parameters to describe the CDR-3 regions,
such as hydrophobicity and charge, but no clear separation be-
tween the two sets was observed (data not shown). It can therefore
be concluded that Kidera Factors are a powerful means of incor-
porating general physico-chemical properties and structural in-
formation into a sequence-based analysis. Interestingly, in the
context of blood repertoire, similar conclusions were reached in a
study by Epstein et al. (Epstein et al., 2014), which used Kidera
factors to analyse TCR repertoires from different individuals.
3.4. Enriched b-sheet content in promiscuous CDR-H3 regions
The variable regions of each of the GF antibodies were modelled
to look for explicit structural differences between members of the
different clusters (see Fig. 4). In each case, the most native-like
representative from a sample of 200 models was selected (pre-
sented in Fig. 4B) (see Materials and Methods for more
information).
Intriguingly, the b-sheet content of the CDR-H3 was highly
enriched in the promiscuous antibody models, particularly in thosePlease cite this article in press as: Laffy, J.M.J., et al., Promiscuous antibodie
to structure and back, Progress in Biophysics and Molecular Biology (201within Cluster 3 (Fig. 4). Moreover, the only promiscuous antibody
not belonging to Cluster 3 (GF9) was also the only one that
appeared to lack the ordered b-sheet seen in the other cases. In fact,
the CDR-H3 secondary structure of GF9 much more closely
resembled a random coil; a feature that was shared amongst all
antibodies in Clusters 1 and 2.
The b-sheet-forming propensities (Prevelige, 1989) of residues
in the CDR-H3 regions (Fig. 5) also reﬂected the results in Fig. 4.
Within Cluster 3, b-sheet breakers (pink) and strong b-sheet
breakers (red) were concentrated at the apices of the CDR-H3s and
were largely absent from their stems, thereby permitting anti-
parallel b-sheet hydrogen bonding. The exception to this was a
serine residue in GF5 (breaker; pink), however its geometry and
neighbouring environment was such that a hydrogen bond still
formed. Contrastingly, the distributions of b-sheet breakers were
far more scattered in members of Clusters 1 and 2. A higher
occurrence of strong b-sheet formers (green) in the stems of Cluster
3 members was also noted. Once again, this observation was less
relevant in GF5. To this point, it is perhaps worth noting that GF5s characterised by their physico-chemical properties: From sequence
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Beyond b-sheet propensities, the degree of CDR-H3 collapse
seemed to correlate well with membership to a particular cluster
(Fig. 5). Cluster 1 CDR-H3members were themost ‘tangled’; Cluster
2 members were comparatively taut and Cluster 3 members were
most extended (forming b-sheet structure) (see Fig. 6).
To assess the statistical signiﬁcance of this ﬁnding and to ensure
that differences in secondary structure content were not simply a
reﬂection of the templates used, Monte Carlo-based simulations
were run on all GF antibodies using the tCONCOORD program (see
Materials and Methods). CDR-H3 secondary structure probabilities
were calculated for the GF ensembles of 500 tCONCOORD struc-
tures and subsequently averaged over the promiscuous and non-
promiscuous sets.
As illustrated in Fig. 5, the CDR-H3 b-sheet content was 33.4%
higher in the promiscuous antibodies compared to the non-
promiscuous antibodies (two-tailed P value < 0.0001) and this
difference was even more pronounced when GF9 was excluded
from the promiscuous set (data not shown). The non-promiscuous
antibodies were also predicted to have 18% more ‘turn’ secondary
structure (deﬁned as 3, 4, and 5 turns and non-hydrogen bonded
bends) (two-tailed P value < 0.0001).
Predicted secondary structure occupancies were also calculated
for the CDR-L3 regions of the promiscuous and non-promiscuous
antibodies however no signiﬁcant differences were observed
(Supplementary Materials Fig. S2).
3.5. Key residues in the CDR-H3 of GF1
To reduce the high dimensionality of the tCONCOORD trajec-
tories and to identify the dominant molecular motions related to
either promiscuous or non-promiscuous antibodies, principalFig. 7. Principal component analysis of CDR-H3 dynamics. (A) The contribution of each atom
measured in nm2. (B) The residues whose atoms contributed most signiﬁcantly to the respe
residues were mapped onto the GF4 model for reference.
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COORD trajectories were taken from each class; GF1 for the pro-
miscuous subset and GF4 for the non-promiscuous subset. As
mentioned earlier in the text, these antibodies were amongst the
most deep-rooted in their respective clusters (Fig. 4A). Further-
more, their CDR-H3 and CDR-L3 loops were determined to be of
approximately the same length and of very high sequence simi-
larity (CDR-H3, 99%; CDR-L3, 95%). In the trajectories of both GF1
and GF4 the dominant global motionwas found to be a side-to-side
‘rocking’ of the heavy and light chain framework regions (Supple-
mentary Materials Fig. S4). When the projection of atoms in the
CDR-H3 and -L3 loops onto PC1 and PC2 were determined, several
residues in the CDR-H3 loops of the promiscuous GF1 antibody, but
not GF4, were also found to contribute to the global motion
accounted for by the ﬁrst and second eigenvectors (Fig. 7). The CDR-
L3 regions were found not to contribute signiﬁcantly to the global
motion in either the ﬁrst or the second eigenvectors (Supplemen-
tary Materials Fig. S5).
Analysis of PC1 and PC2 highlighted four particularly dynamic
residues in the CDR-H3 of GF1: Lys100, Asp100B, His100C and
Trp100E (Chothia numbering deﬁnition; Fig. 7A). Interestingly,
these residues are concentrated at the apex of the CDR-H3 b-sheet
(Fig. 7B). Furthermore, some of these residues contain features that
are indicative of binding versatility. Firstly, residues such as Lys and
Trp are often found at binding interfaces due to their ability to
adapt to both hydrophobic and hydrophilic environments (Mian
et al., 1991). Residues with a large surface area (Lys, His, Trp)
should also contribute favourably to binding free energies with
antigen due to their participation in van der Waals' interactions
(Chothia and Lesk, 1987; Chothia et al., 1989; Gelles and Klapper,
1978). Lastly, some residues, including Tyr and Trp, are intrinsi-
cally ﬂexible (Mian et al., 1991); a property that has previously beenin the CDR-H3 loop of GF1 (red) and GF4 (blue) to the ﬁrst and second eigenvectors
ctive PCs in GF1 were labelled in (A) and mapped onto the GF1 model. Corresponding
s characterised by their physico-chemical properties: From sequence
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(Fornili et al., 2013). Such residues could sample a wider range of
dihedral angles and adjust their ﬁt to accommodate different
antigens.
3.6. Putative binding mechanisms
We hypothesize that the advantage of a protruding b-sheet-rich
CDR-H3 in the promiscuous antibodies lies in the inability of its
residues to partake in intra-molecular interactions. Instead, such
outwardly positioned residues would be most effectively placed to
encourage interactions with foreign molecules. In contrast, the
lower occurrence of b-sheet in the non-promiscuous CDR-H3 loops
would result in a higher number of ‘rigidifying’ intra-molecular
CDR-H3 contacts. This could explain why the CDR-H3 residues in
GF4 were less dynamic than their counterparts in GF1 despite
residing in an otherwise ﬂexible random coil (Fig. 7).
Beyond this, the ﬁndings presented here suggest that speciﬁc
residues in the GF antibodies confer promiscuity, as was found in a
large-scale analysis of multi-binding proteins (Fornili et al., 2013).
The dominant nature of the promiscuous CDR-H3 could permit the
exposure of local and chemically versatile neighbourhoods of
amino acids with conﬁgurations free of the steric or structural
constraints normally expected within the antibody-combining site.
4. Conclusions
Binding promiscuity is a characteristic of many proteins and is
an essential feature for efﬁcient cellular communication. In the past
(Fornili et al., 2013) we characterised the essential role played by
promiscuous residues at the surface of multi-binding proteins
(hubs) and revealed an important feature the ﬂexibility exerted by
these residues and their enhanced motion. This plasticity can be
efﬁciently exploited in supporting diversity of interaction and
effective binding. Here we focused on another important class of
proteins, antibodies, and highlighted the important role of physico-
chemical properties of speciﬁc residues at the CDR-H3 in conferring
promiscuous behaviour to a set of antibodies tested for multiple
binding to a small panel of antigens in-vitro. Interestingly, we found
that it is not the entire region of the paratope that has to exhibit
ﬂexibility to effectively modulate promiscuous binding, but this
comes at a compromise between the b-sheet content of the CDR-H3
that can hold in place and protrude out of the antibody combining-
site, thereby ‘offering’ to the epitope the crucially binding effective
residues that can exert their plastic role and explore multiple
binding conditions. In analogy with the previous ﬁndings, the
promiscuity is relegated to only few versatile and intrinsically
ﬂexible residues. These are concentrated at the apex of the CDR-H3
b-sheet and found to contribute to the global motion accounted for
by the ﬁrst and second eigenvectors of the variable framework
region. The observed properties were crucially different from the
ones measured for a comparable class of antibodies that showed no
binding preferences in the same tested conditions.
The ﬁndings presented here can have important applications in
the design of speciﬁc antibodies devoid of promiscuous behaviour,
as it is well known that in many circumstances antibodies elicited
towards a speciﬁc antigen are found to bind to structurally unre-
lated epitopes (James and Tawﬁk, 2009). Additionally, the role of
speciﬁc physicochemical determinants in promiscuous protein ac-
tivities could pave the way to alternative approaches to directed
evolution of novel protein functions (Buchholz and Stewart, 2001).
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